PuriCore Plc Grant of Options (5921K)

TIDMPURI

RNS Number : 5921K

PuriCore Plc

22 September 2016

PuriCore plc

("PuriCore" or the "Company")

Grant of Options

22 September 2016 - PuriCore plc (AIM: PURI), announces the grant of share options to Dr. Christian Peters, Chief Medical Officer, to subscribe for up to 500,000 new ordinary shares of 10p each in the capital of the Company (the "Options").

The Options, granted on 21 September 2016, have an exercise price of 27.00 pence each and a five year term. The Options vest one-third per year on each of the three anniversaries of the grant date. Dr. Peters holds no other options over shares in the Company.

Enquiries:

 
 PuriCore plc                            [phone] 
 Alex Martin, Chief Executive Officer 
  Marella Thorell, Chief Financial 
  Officer and Chief Operating Officer 
 
 
 
 FTI Consulting                          [phone] 
 Simon Conway / Mo Noonan 
 
 
 N+1 Singer (Nominated Adviser 
  & Broker)                              [phone] 
 Aubrey Powell / Jen Boorer 
 

About PuriCore

PuriCore is an emerging specialty biopharmaceutical company focused on developing novel immunomodulatory therapies to protect and improve the lives of adults and children. The Company has initiated a drug development program, based upon its proprietary hypochlorous acid technology at high concentrations. The Company believes their formulations have novel immunomodulatory activity with potential application for the treatment of diseases in a number of therapeutic areas such as Dermatology, Ophthalmology and potentially rare diseases. For more details, go to the Company's website: www.puricore.com

 
1.  Details of the Person Discharging Managerial 
     Responsibility ("PDMR") / person closely 
     associated with them ("PCA") 
a)  Name                       CHRISTIAN PETERS 
2.  Reason for the notification 
a)  Position                    CHIEF MEDICAL OFFICER 
     /status 
b)  Initial notification        INITIAL NOTIFICATION 
     / amendment 
3.  Details of the Issuer 
a)  Name                        PURICORE PLC 
b)  LEI code                     N/A 
4.  Details of the transaction(s): section to 
     be repeated for (i) each type of instrument; 
     (ii) each type of transaction; (iii) each 
     date; and (iv) each place where transactions 
     have been conducted 
a)  Description                ORDINARY SHARES IN PURICORE PLC 
     of the financial           ISIN: GB00B3XBCR18 
     instrument, 
     type of 
     instrument 
     Identification 
     code 
b)  Nature of                   GRANT OF OPTIONS OVER 500,000 SHARES 
     the transaction             UNDER THE COMPANY'S PuriCore Executive 
                                 Omnibus Incentive Plan 
c)  Price(s)                    Price(s)  Volume(s) 
     and volume(s) 
                                 27p       500,000 
d)  Aggregated 
     information                 N/A 
     Aggregated 
     volume 
     Price 
e)  Date of                    21 SEPTEMBER 2016 
     the transaction 
f)  Place of                    OUTSIDE A TRADING VENUE 
     the transaction 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHPGUPGBUPQGWP

(END) Dow Jones Newswires

September 22, 2016 09:15 ET (13:15 GMT)